Literature DB >> 16909902

Rotavirus assembly: an alternative model that utilizes an atypical trafficking pathway.

S Chwetzoff1, G Trugnan.   

Abstract

We review here recent advances in our knowledge on trafficking and assembly of rotavirus and rotaviral proteins in intestinal cells. Assembly of rotavirus has been extensively studied in nonpolarized kidney epithelial MA104 cells, where several data indicate that most if not all the steps of rotavirus assembly take place within the endoplasmic reticulum (ER) and that rotavirus is release upon cell lysis. We focus here on data obtained in intestinal cells that argue for another scheme of rotavirus assembly, where the final steps seem to take place outside the ER with an apically polarized release of rotavirus without significant cell lysis. One of the key observations made by different groups is that VP4 and other structural proteins interact substantially with specialized membrane microdomains enriched in cholesterol and sphingolipids termed rafts. In addition, recent data point to the fact that VP4 does not localize within the ER or the Golgi apparatus in infected intestinal cells. The mechanisms by which VP4, a cytosolic protein, may be targeted to the apical membrane in these cells and assembles with the other structural proteins are discussed. The identification of cellular proteins such as Hsp70, flotillin, rab5, PRA1 and cytoskeletal components that interact with VP4 may help to define an atypical polarized trafficking pathway to the apical membrane of intestinal cells that will be raft-dependent and by-pass the classical exocytic route.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16909902      PMCID: PMC7122644          DOI: 10.1007/3-540-30773-7_9

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  78 in total

1.  The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site.

Authors:  Philip R Dormitzer; Zhen-Yu J Sun; Gerhard Wagner; Stephen C Harrison
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

Review 2.  Role of Ca2+in the replication and pathogenesis of rotavirus and other viral infections.

Authors:  M C Ruiz; J Cohen; F Michelangeli
Journal:  Cell Calcium       Date:  2000-09       Impact factor: 6.817

3.  Interactions of rotavirus VP4 spike protein with the endosomal protein Rab5 and the prenylated Rab acceptor PRA1.

Authors:  Vincent Enouf; Serge Chwetzoff; Germain Trugnan; Jean Cohen
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

Review 4.  The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes.

Authors:  Walter Nickel
Journal:  Eur J Biochem       Date:  2003-05

5.  Rotavirus gene silencing by small interfering RNAs.

Authors:  Miguel Angel Déctor; Pedro Romero; Susana López; Carlos F Arias
Journal:  EMBO Rep       Date:  2002-11-21       Impact factor: 8.807

6.  Symmetric infection of rotavirus on polarized human intestinal epithelial (Caco-2) cells.

Authors:  L Svensson; B B Finlay; D Bass; C H von Bonsdorff; H B Greenberg
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

7.  Glycosphingolipid binding specificities of rotavirus: identification of a sialic acid-binding epitope.

Authors:  C Delorme; H Brüssow; J Sidoti; N Roche; K A Karlsson; J R Neeser; S Teneberg
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  The cytoplasmic/transmembrane domain of dipeptidyl peptidase IV, a type II glycoprotein, contains an apical targeting signal that does not specifically interact with lipid rafts.

Authors:  T A Slimane; C Lenoir; V Bello; J L Delaunay; J W Goding; S Chwetzoff; M Maurice; J A Fransen; G Trugnan
Journal:  Exp Cell Res       Date:  2001-10-15       Impact factor: 3.905

9.  Dipeptidyl peptidase IV (CD 26) gene expression in enterocyte-like colon cancer cell lines HT-29 and Caco-2. Cloning of the complete human coding sequence and changes of dipeptidyl peptidase IV mRNA levels during cell differentiation.

Authors:  D Darmoul; M Lacasa; L Baricault; D Marguet; C Sapin; P Trotot; A Barbat; G Trugnan
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

10.  Global illness and deaths caused by rotavirus disease in children.

Authors:  Umesh D Parashar; Erik G Hummelman; Joseph S Bresee; Mark A Miller; Roger I Glass
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

View more
  6 in total

1.  Hepatitis C Virus Is Released via a Noncanonical Secretory Route.

Authors:  Karen Bayer; Carina Banning; Volker Bruss; Linda Wiltzer-Bach; Michael Schindler
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

2.  Silencing of rotavirus NSP4 or VP7 expression reduces alterations in Ca2+ homeostasis induced by infection of cultured cells.

Authors:  José Luis Zambrano; Yuleima Díaz; Franshelle Peña; Esmeralda Vizzi; Marie-Christine Ruiz; Fabián Michelangeli; Ferdinando Liprandi; Juan Ernesto Ludert
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103

3.  Bluetongue virus outer capsid protein VP5 interacts with membrane lipid rafts via a SNARE domain.

Authors:  Bishnupriya Bhattacharya; Polly Roy
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

4.  Role of lipids on entry and exit of bluetongue virus, a complex non-enveloped virus.

Authors:  Bishnupriya Bhattacharya; Polly Roy
Journal:  Viruses       Date:  2010-05-18       Impact factor: 5.818

5.  Interaction between Bluetongue virus outer capsid protein VP2 and vimentin is necessary for virus egress.

Authors:  Bishnupriya Bhattacharya; Rob J Noad; Polly Roy
Journal:  Virol J       Date:  2007-01-15       Impact factor: 4.099

Review 6.  Assembly and Cellular Exit of Coronaviruses: Hijacking an Unconventional Secretory Pathway from the Pre-Golgi Intermediate Compartment via the Golgi Ribbon to the Extracellular Space.

Authors:  Jaakko Saraste; Kristian Prydz
Journal:  Cells       Date:  2021-02-26       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.